Skip to content

Research and Development of Key Technologies for multimodal rehabilitation of post-tuberculosis lung Disease in Xinjiang Region and Homogeneous Application Research at the Grassroots level

Research and Development of Key Technologies for multimodal rehabilitation of post-tuberculosis lung Disease in Xinjiang Region and Homogeneous Application Research at the Grassroots level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113642
Enrollment
Unknown
Registered
2025-12-01
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post tuberculosis lung disease

Interventions

Experimental group:Experimental group: On the basis of the control group (clinical routine treatment, including clinical symptomatic drug treatment and nursing), patients in the experimental group wil
Strength training includes upper and lower limb strength exercises, such as sandbag and elastic band training, 2-3 times a week, with 3 groups trained each time, 10-15 times per group
Flexibility training, such as Eight Section Brocade and Xinjiang Ethnic Dance, is conducted 2-3 times a week for 15-20 minutes each time. During the exercise process, professional rehabilitation thera

Sponsors

Aktao County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 18 and above; 2.Diagnosed clinically as pulmonary tuberculosis, and have completed standardized anti tuberculosis treatment and sputum bacteria have turned negative for more than 6 months; 3.There are PTLD related symptoms, such as shortness of breath, cough, decreased exercise endurance, etc; 4.Pulmonary function test shows FEV1/FVC<70%; 5.High resolution chest CT confirms patients with pulmonary fibrosis or bronchiectasis; 6.Voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Active tuberculosis infection; 2.Combined with severe pulmonary arterial hypertension; 3.Mental illness or cognitive impairment (MMSE score<24), unable to cooperate with the research process; 4.I am currently participating in other clinical trials that may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
FEV1/FVC;A 6-minute walk test;

Secondary

MeasureTime frame
New York Heart Association;Disease Shame Scale;Hamilton Anxiety Scale;Hamilton Depression Scale;Short Form 36;Activity of Daily Living Scale;

Countries

China

Contacts

Public ContactYing Liang;Xiaofei Yao

Aktao County People's Hospital;Nanchang University Affiliated Rehabilitation Hospital

15270973720@163.com+86 908 572 6932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026